2011 Aug;56(8):2349-53
Who Should Consider Oral Semaglutide
This was not particularly surprising for researchers, as GLP-1 acts on the same brain regions that are involved in craving, reward, and motivation systems - largely driven by dopamine pathways
The KLOW 80mg vial contains KPV 10mg (Lys-Pro-Val, the C-terminal tripeptide of alpha-melanocyte-stimulating hormone at residues 11 to 13, 342.4 g/mol, CAS 64790-08-5), BPC-157 10mg (pentadecapeptide GEPPPGKPADDAGLV, 1419.53 g/mol, CAS 137525-51-0), TB-500 10mg (synthetic thymosin beta 4, 43 residues, 4963.4 g/mol, CAS 77591-33-4) and GHK-Cu 50mg (glycyl-L-histidyl-L-lysine copper(II) complex, 403.9 g/mol, CAS 89030-95-5), co-lyophilised in one container